Clinical
RSSArticles
-
Clostridioides difficile Infection: Fecal Microbiota Transplantation vs. Antibiotics
Relative to vancomycin or metronidazole treatment of recurrent Clostridioides difficile infection, treatment with fecal microbiota transplantation is associated with a lower risk of bloodstream infection, shorter hospital length of stay, and improved survival.
-
Dual Antiplatelet Therapy Increases Serious Hemorrhages Following TIA or Minor Stroke
Caution should be taken and close observation of patients maintained when treating with dual antiplatelet therapies.
-
Soft Drinks and Death
Investigators found drinking more soft drinks, both artificially sweetened and sugar-sweetened, is associated with a higher risk of death, cardiovascular illness, and digestive illnesses.
-
Airplane-Triggered Headaches
Severe, unilateral headaches that occur during airplane travel, particularly during landing, are most likely a variant of migraine headaches triggered by changes in cabin pressure.
-
When to Administer the 13-Valent Pneumococcal Conjugate Vaccine: A Review of the ACIP Recommendations
Recently revised guidelines no longer recommend the 13-valent pneumococcal conjugate vaccine for most healthy adults.
-
Seven Days of Antibiotics Was Noninferior to 14 Days for Gram-Negative Rod Bacteremia
In patients with gram-negative rod bacteremia, patients receiving seven days of antibiotics had similar 90-day mortality, readmission rates, and rates of recurrent bacteremia as patients receiving 14 days of antibiotic.
-
Balanced Crystalloids Reduce Mortality in Critically Ill Adults With Sepsis or Septic Shock
Compared to saline, balanced crystalloids reduced in-hospital mortality and major adverse kidney events within 30 days in critically ill patients with sepsis or septic shock.
-
The Epidemic of Vaping-Associated Lung Injury
Since June 2019, there has been a considerable rise in reported cases of vaping-associated lung injury.
-
Infectious Disease Alert Updates
Objects of Delusional Infestation; Urine Eosinophils Unreliable; Tecovirimat for Laboratory-Acquired Vaccinia
-
Omeprazole Magnesium, Amoxicillin, and Rifabutin Delayed-Release Capsules (Talicia)
The FDA has approved a fixed-dose combination, rifabutin-based (RFB) regimen to treat Helicobacter pylori infection.